At what pace is the bilirubin blood test market growing, and what is its estimated value?
The bilirubin blood test market size has grown strongly in recent years. It will grow from $1.37 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the increasing prevalence of liver diseases, growth in neonatal care, technological advancements, rising health awareness, healthcare infrastructure development, regulatory approvals and guidelines, and increased adoption of point-of-care testing.
The bilirubin blood test market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for early diagnosis, expansion of diagnostic laboratories, rising incidence of chronic diseases, emerging markets growth, integration of advanced analytics, increased research funding. Major trends in the forecast period include development of non-invasive testing methods, integration with digital health solutions, advances in home testing kits, enhanced test accuracy and speed, personalized medicine approaches, smart diagnostic devices, development of portable devices.
Get Your Free Sample of The Global Bilirubin Blood Test Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp
What are the top drivers to the rising demand in the bilirubin blood test market?
The growing incidences of liver diseases are expected to propel the growth of the bilirubin blood test market going forward. Liver diseases refer to a range of conditions that impair the liver’s ability to function properly, which can result from various causes such as infections, alcohol abuse, or metabolic disorders. The increasing number of liver disease cases can be attributed to rising rates of obesity, excessive alcohol consumption, viral infections, and unhealthy lifestyle choices, which collectively contribute to liver dysfunction and damage. Liver disease can significantly impact bilirubin levels in the body, and bilirubin blood tests help diagnose and monitor liver function, providing crucial insights into the health of patients while aiding healthcare providers in managing and treating liver-related conditions effectively. For instance, in April 2024, according to the European Centre for Disease Prevention and Control, a Sweden-based government health agency, there were 28,855 recorded cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, an increase of 78% compared to 16,187 cases in 2021. Additionally, the number of cases in 2022, totaling 28,420, represents a crude rate of 8.5 cases per 100,000 people. Therefore, growing incidences of liver diseases are driving the bilirubin blood test market.
How is the bilirubin blood test market segmented?
The bilirubin blood test market covered in this report is segmented –
1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test
2) By Age Group: Adults, Pediatrics, Infants
3) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection
2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions
3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report
Who are the top competitors in the bilirubin blood test market?
Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.
What significant trends should we anticipate in the bilirubin blood test market over the forecast period?
Major companies operating in the bilirubin blood test market are adopting a strategic partnership approach to expand their reach and enhance their service offerings. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology solutions company, signed an exclusive distributor agreement with Techno Orbits in Saudi Arabia for Calmark’s bilirubin test designed for newborns. Techno Orbits will handle the distribution and sales of the product, leveraging its existing network and relationships, including with the Ministry of Health. This partnership aims to facilitate the introduction of Calmark’s bilirubin test into the Saudi market, where regulatory registration is expected to take 3 to 6 months.
Which regional trends are influencing the bilirubin blood test market, and which area dominates the industry?
North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Bilirubin Blood Test Market Report 2025 Offer?
The bilirubin blood test market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
The bilirubin blood test refers to a diagnostic procedure used to measure the levels of bilirubin in the blood. This test helps in assessing liver function and diagnosing conditions such as jaundice and liver disease. It is essential for evaluating bilirubin metabolism and detecting abnormalities related to liver health.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18522
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
